Novilla Pharmaceuticals
- Biotech or pharma, therapeutic R&D
Novilla Pharmaceuticals – transforming drug delivery with proprietary AI and novel administration technology that solves the holy grail of medicine- delivering drugs only to where they need to act.
The AI platform’s first drug candidate is already Phase II ready for Gout flares, and has demonstrated higher efficacy with no observed side effects in its Phase 1B trial, compared to high prevalence of GI issues from the standard of care.
Renowned neuro oncologist, Dr. Shashi Kori (Pain Commissioner of Florida, MAP Pharma, GSK), founded Novilla to leverage new innovations in AI by DARPA and Harvard scientists.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}